156 related articles for article (PubMed ID: 4290017)
1. The treatment of erythema nodosum leprosum with B.663. A controlled study.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
[No Abstract] [Full Text] [Related]
2. Erythema nodosum leprosum.
Fowler PD
Int J Lepr Other Mycobact Dis; 1967; 35(3):397-8. PubMed ID: 4318423
[No Abstract] [Full Text] [Related]
3. Erythema nodosum leprosum.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(3):400-1. PubMed ID: 4318424
[No Abstract] [Full Text] [Related]
4. B.663 and erythema nodosum leprosum.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
[No Abstract] [Full Text] [Related]
5. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
Helmy HS; Pearson JM; Waters MF
Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
[No Abstract] [Full Text] [Related]
6. A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).
Imkamp FM
Lepr Rev; 1968 Jul; 39(3):119-25. PubMed ID: 4298736
[No Abstract] [Full Text] [Related]
7. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
8. An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum.
Waters MF
Lepr Rev; 1971 Mar; 42(1):26-42. PubMed ID: 4338720
[No Abstract] [Full Text] [Related]
9. Erythema nodosum leprosum.
Browne SG
Int J Lepr Other Mycobact Dis; 1967; 35(3):395-7. PubMed ID: 5630360
[No Abstract] [Full Text] [Related]
10. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
12. Erythema nodosum leprosum.
Kwittken J
Int J Lepr Other Mycobact Dis; 1968; 36(1):94-5. PubMed ID: 5689653
[No Abstract] [Full Text] [Related]
13. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
14. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
[TBL] [Abstract][Full Text] [Related]
15. Erythema nodosum leprosum.
Crawford CL
Lancet; 1973 Jun; 1(7814):1247. PubMed ID: 4122590
[No Abstract] [Full Text] [Related]
16. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
17. The etiology of erythema nodosum leprosum.
Pettit JH; Waters MF
Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035
[No Abstract] [Full Text] [Related]
18. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
19. Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.
Hastings RC; Trautman JR; Enna CD; Jacobson RR
Clin Pharmacol Ther; 1970; 11(4):481-7. PubMed ID: 4913866
[No Abstract] [Full Text] [Related]
20. Story behind the clinical trial of B.663 in leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
